Skip to main content
Erschienen in: Tumor Biology 5/2016

19.11.2015 | Original Article

The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line

verfasst von: Jing Zhang, Dongmei Wang, Na Hu, Qian Wang, Shanice Yu, Jun Wang

Erschienen in: Tumor Biology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

This study aims to design and generate recombinant lentiviral vector containing the complete coding sequence (CDS) region of human serine protease inhibitor Kazal type 1 gene (SPINK1) and establish a human pancreatic cancer cell line (AsPC-1) stably overexpressing SPINK1. Then, to assess the proliferative and oncogenic effects of upregulated SPINK1 gene on pancreatic cancer AsPC-1 cells using different methods. Initially, the target coding sequence (CDS) of SPINK1 was amplified by polymerase chain reaction (PCR) and the synthesized product was subsequently subcloned into the lentiviral vector. The construction of recombinant SPINK1 gene was verified by the restriction digestion and sequencing analysis. The lentiviral particles carrying SPINK1 gene were produced by co-transfection of the recombination lentiviral vector and the packaging mix plasmids into 293 T cells and filtered and concentrated before AsPC-1 cells were infected by the virus particles. The cells transduced were differentially selected with puromycin, and the clones that highly expressed SPINK1 were chosen by real-time PCR and confirmed by Western blot after 7 weeks. The stably transduced AsPC-1 cell line showed significantly increased metabolic and proliferative capability using CCK-8 and Trypan Blue assays (P < 0.001). Cell cycle and DNA content analysis by flow cytometry showed that upregulated SPINK1 elicited significant increase in the percentage of AsPC-1 cells in the S and G2/M phase (P < 0.001). Clone formation assay demonstrated that the number of the colonies formed in the experimental group was greater than that in the control parental cells (P < 0.001). It was concluded that a stable AsPC-1 cell line capable of overexpressing SPINK1 had been successfully created, and that the proliferative capacity of AsPC-1 pancreatic cancer cells was significantly raised by SPINK1 upregulation as well as the ability of a single AsPC-1 cell to grow into a colony.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Yutong H et al. Pancreatic cancer incidence and mortality patterns in China, 2011. Chin J Cancer Res. 2015;27(1):29–37. Yutong H et al. Pancreatic cancer incidence and mortality patterns in China, 2011. Chin J Cancer Res. 2015;27(1):29–37.
2.
Zurück zum Zitat Kozak G, Blanco FF, Brody JR. Novel targets in pancreatic cancer research. Semin Oncol. 2015;42(1):177–87.CrossRefPubMed Kozak G, Blanco FF, Brody JR. Novel targets in pancreatic cancer research. Semin Oncol. 2015;42(1):177–87.CrossRefPubMed
3.
Zurück zum Zitat Ida S et al. SPINK1 status in colorectal cancer, impact on proliferation, and role in colitis-associated cancer. Mol Cancer Res. 2015;13(7):1130–8.CrossRefPubMed Ida S et al. SPINK1 status in colorectal cancer, impact on proliferation, and role in colitis-associated cancer. Mol Cancer Res. 2015;13(7):1130–8.CrossRefPubMed
4.
Zurück zum Zitat Ogata N. Demonstration of pancreatic secretory trypsin inhibitor in serum-free culture medium conditioned by the human pancreatic carcinoma cell line CAPAN-1. J Biol Chem. 1988;263(26):13427–31.PubMed Ogata N. Demonstration of pancreatic secretory trypsin inhibitor in serum-free culture medium conditioned by the human pancreatic carcinoma cell line CAPAN-1. J Biol Chem. 1988;263(26):13427–31.PubMed
5.
Zurück zum Zitat Nobuyuki O et al. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. J Hepatobiliary Pancreat Sci. 2013;20(6):620–7.CrossRef Nobuyuki O et al. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. J Hepatobiliary Pancreat Sci. 2013;20(6):620–7.CrossRef
6.
Zurück zum Zitat Marchbank T, Mahmood A, Playford RJ. Pancreatic secretory. Trypsin inhibitor causes autocrine-mediated migration and invasion in bladder cancer and phosphorylates the EGF receptor, Akt2 and Akt3, and ERK1 and ERK2. Am J Physiol Renal Physiol. 2013;305(3):382–9.CrossRef Marchbank T, Mahmood A, Playford RJ. Pancreatic secretory. Trypsin inhibitor causes autocrine-mediated migration and invasion in bladder cancer and phosphorylates the EGF receptor, Akt2 and Akt3, and ERK1 and ERK2. Am J Physiol Renal Physiol. 2013;305(3):382–9.CrossRef
7.
Zurück zum Zitat Ohmachi Y et al. Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor. Int J Pancreatol. 1994;15(1):65–73.PubMed Ohmachi Y et al. Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor. Int J Pancreatol. 1994;15(1):65–73.PubMed
8.
Zurück zum Zitat Ohmuraya M, Yamamura K. The roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases. J Exp Anim. 2011;60(5):433–44.CrossRef Ohmuraya M, Yamamura K. The roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases. J Exp Anim. 2011;60(5):433–44.CrossRef
9.
Zurück zum Zitat Ozaki N et al. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor. Mol Cancer Res. 2009;7(9):1572–81.CrossRefPubMed Ozaki N et al. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor. Mol Cancer Res. 2009;7(9):1572–81.CrossRefPubMed
10.
Zurück zum Zitat López-Sáez JF et al. Cell proliferation and cancer. Histol Histopathol. 1998;13(14):1197–214.PubMed López-Sáez JF et al. Cell proliferation and cancer. Histol Histopathol. 1998;13(14):1197–214.PubMed
12.
Zurück zum Zitat Taylor HE et al. The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol. 2014;1:592–603.CrossRef Taylor HE et al. The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol. 2014;1:592–603.CrossRef
13.
Zurück zum Zitat Shearer RF, Saunders DN. Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives. Genes Cells. 2015;20(1):1–10.CrossRefPubMed Shearer RF, Saunders DN. Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives. Genes Cells. 2015;20(1):1–10.CrossRefPubMed
14.
Zurück zum Zitat Chen Y et al. Construction and application of a lentiviral vector of single-chain variable fragment antibody against human hepatocyte growth factor receptor. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;30(9):960–3. Chinese.PubMed Chen Y et al. Construction and application of a lentiviral vector of single-chain variable fragment antibody against human hepatocyte growth factor receptor. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;30(9):960–3. Chinese.PubMed
15.
Zurück zum Zitat Appaiahgari MB, Vrati S. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opin Biol Ther. 2015;15(3):337–51.CrossRefPubMed Appaiahgari MB, Vrati S. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opin Biol Ther. 2015;15(3):337–51.CrossRefPubMed
16.
Zurück zum Zitat Tominaga H et al. A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal Commun. 1999;36:47–50.CrossRef Tominaga H et al. A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal Commun. 1999;36:47–50.CrossRef
17.
Zurück zum Zitat Spyratos F et al. Biology of the cell DNA content and cell cycle analysis by flow cytometry in clinical samples: application in breast cancer. Biol Cell. 1993;78(1–2):69–72.CrossRefPubMed Spyratos F et al. Biology of the cell DNA content and cell cycle analysis by flow cytometry in clinical samples: application in breast cancer. Biol Cell. 1993;78(1–2):69–72.CrossRefPubMed
18.
Zurück zum Zitat Favoni RE, de Cupis A. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach. Pharmacol Rev. 2000;52(2):179–206.PubMed Favoni RE, de Cupis A. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach. Pharmacol Rev. 2000;52(2):179–206.PubMed
19.
Zurück zum Zitat Wood CE et al. Scientific and regulatory policy committee (SRPC) review: interpretation and use of cell proliferation data in cancer risk assessment. Toxicol Pathol. 2015;43(6):760–75.CrossRefPubMed Wood CE et al. Scientific and regulatory policy committee (SRPC) review: interpretation and use of cell proliferation data in cancer risk assessment. Toxicol Pathol. 2015;43(6):760–75.CrossRefPubMed
20.
Zurück zum Zitat Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.CrossRefPubMed Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.CrossRefPubMed
21.
Zurück zum Zitat Niinobu T et al. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor. J Exp Med. 1990;172:1133–42.CrossRefPubMed Niinobu T et al. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor. J Exp Med. 1990;172:1133–42.CrossRefPubMed
22.
Zurück zum Zitat Ohmuraya M, Yamamura K. Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases. Exp Anim. 2011;60(5):433–44.CrossRefPubMed Ohmuraya M, Yamamura K. Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases. Exp Anim. 2011;60(5):433–44.CrossRefPubMed
Metadaten
Titel
The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line
verfasst von
Jing Zhang
Dongmei Wang
Na Hu
Qian Wang
Shanice Yu
Jun Wang
Publikationsdatum
19.11.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 5/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4405-z

Weitere Artikel der Ausgabe 5/2016

Tumor Biology 5/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.